Priora, M.; Becciolini, A.; Celletti, E.; Di Penta, M.; Lo Gullo, A.; Paroli, M.; Bravi, E.; Andracco, R.; Nucera, V.; Ometto, F.;
et al. Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup—A Multicenter Study. Medicina 2024, 60, 1982.
https://doi.org/10.3390/medicina60121982
AMA Style
Priora M, Becciolini A, Celletti E, Di Penta M, Lo Gullo A, Paroli M, Bravi E, Andracco R, Nucera V, Ometto F,
et al. Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup—A Multicenter Study. Medicina. 2024; 60(12):1982.
https://doi.org/10.3390/medicina60121982
Chicago/Turabian Style
Priora, Marta, Andrea Becciolini, Eleonora Celletti, Myriam Di Penta, Alberto Lo Gullo, Marino Paroli, Elena Bravi, Romina Andracco, Valeria Nucera, Francesca Ometto,
and et al. 2024. "Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup—A Multicenter Study" Medicina 60, no. 12: 1982.
https://doi.org/10.3390/medicina60121982
APA Style
Priora, M., Becciolini, A., Celletti, E., Di Penta, M., Lo Gullo, A., Paroli, M., Bravi, E., Andracco, R., Nucera, V., Ometto, F., Lumetti, F., Farina, A., Del Medico, P., Colina, M., Ravagnani, V., Scolieri, P., Larosa, M., Visalli, E., Addimanda, O.,
... Parisi, S.
(2024). Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup—A Multicenter Study. Medicina, 60(12), 1982.
https://doi.org/10.3390/medicina60121982
